⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 28, 2025Tobacco Induced DiseasesOpen Access

Concept flavor names from English language ENDS advertising in the USA, 2015–2020

Ryan David Kennedy Lauren Czaplicki Meghan Bridgid Moran

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study identifies and describes flavor names in ENDS advertising during 2015-2020, emphasizing their potential impact on tobacco use.
Analysis focused on ENDS advertising across the USA, revealing shifts in marketing strategies and messaging tactics.
Methodology involved examining regulatory documents and advertisements from major tobacco retailers, highlighting significant trends.
The findings suggest a need for stricter regulations on ENDS advertising to mitigate tobacco-related health risks.

Implication

Analysis of flavor names in ENDS advertising by the Food and Drug Administration, highlighting trends in tobacco use messaging.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kennedy et al. (2025) studied this question.

synapsesocial.com/papers/68bb3ef72b87ece8dc95777a https://doi.org/10.18332/tid/205762

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1P0068Clinical, demographic and technical drivers of the IBD microbiome: an interim baseline analysis of the IBD-RESPONSE studyCohort Study · 2026
2DOP107Mirikizumab provides positive histologic and endoscopic outcomes in patients with moderately to severely active Ulcerative ColitisLate-Phase Clinical Trial · 2026
3P1045The impact of patient and public involvement and engagement (PPIE) on the design and operationalisation of a multi-centre inception cohort study: Insights from Open-IBDCohort Study · 2026
4DOP005Mirikizumab treatment reduces Crohn’s disease-related surgery and hospitalization rates: analyses from VIVID-1RCT · 2026
51639-P: Reduction in Incident Type 2 Diabetes with National Diabetes Prevention Program/Intensive Lifestyle Intervention: Results from the Reality Research Networkcohort · 2026

More related papers

P0578Second-line adalimumab is a viable therapeutic option after infliximab failure in perianal Crohn’s disease: a real-world study2026
P0184Improvement in fatigue but not joint pain and stiffness in Inflammatory Bowel Disease patients treated with advanced therapies: Interim findings from IBD-RESPONSE2026
P0639Real-World Effectiveness, Safety, and Dose Modifications of Upadacitinib in Patients with Crohn’s Disease: A Canadian Multicenter Study2026

More from Tobacco Induced Diseases

Secondhand smoke exposure among patients with coronary heart disease in a tertiary Grade A hospital in China: A qualitative study of lived experience and sociocultural challengesTue,
Smoking prevalence, perceptions and cessation practices among dental hygienists in Japan: A cross-sectional studyTue,